SUPER CRITICAL CO2 (SCCO2) TECHNOLOGY FOR
DECELLULARIZATION , IMPREGNATION & STERILIZATION OF TISSUES
HCM-Medical has developed a novel decellularization & sterilization of xenograft & allograft –derived biological
scaffold tissues using scCO2 technology with minimal/no damage to native Extra Cellular Matrix(ECM) composition
& growth factor resulting in an excellent biocompatibility & tissue integration upon implantation. HCM currently
manufactures CE/FDA approved collagen membranes, bone fillers derived from xenografts & allografts using scCO2
technology.
